How can women with liver diseases or organ transplants have healthier pregnancies? Careful, multidisciplinary management is key. This session will provide key updates in this area, covering topics like contraception use and pregnancy management across a spectrum of liver diseases, including the liver transplant population.

Natalie Bzowej
Christine Doligalski
Michael Heneghan
Monika Sarkar
Kidist Yimam

Don’t overlook any of the groundbreaking basic science research presented at The Liver Meeting®. New this year, an expert will briefly review all the basic science abstracts presented at the meeting in one condensed session.

Gavin E. Arteel

Harmful alcohol use accounts for three million annual global deaths. Experts discuss the global health burden of alcohol-related liver disease (ALD), reporting on ALD’s impact in Africa, Latin America and Asia, region-specific factors that promote or hinder solutions and how forthcoming AASLD guidance on ALD may serve as a template to implement effective prevention and treatment strategies worldwide.

Juan Arab
Sumeet Asrani
Helena Cortez-Pinto
Hailemichael Desalegn Mekonnen
Michael Lucey
Jessica Mellinger
K Rajender Reddy
Shiv Kumar Sarin

If you are a general practitioner caring for patients with a variety of liver diseases, this hepatology update is designed for your needs. Review significant new findings in hepatology and how they may affect current clinical practice, ask questions and discuss challenges faced in daily clinical settings.

Manhal Izzy

HCV-infected organs are now being used for transplantation to HCV-uninfected recipients. This program will review existing data on both liver and non-liver transplantation from HCV-positive donors to HCV-negative recipients and key ethical and practical issues related to HCV-infected donor organs, including whether this should be done only in clinical trials or could be accepted as standard of care.

Emily Blumberg
Christine Durand
Jordan J. Feld
Paul Yien Kwo
Susanna Naggie
Norah Terrault

The Diversity and Inclusion Committee promotes health disparities research and efforts to improve health outcomes among ethnic and racial groups who carry a higher burden of liver disease. Based on positive feedback from the 2018 workshop on Ethnic and Racial Disparities in Liver Disease, this two-hour workshop reviews current programmatic efforts to eliminate disparate outcomes in liver disease and liver transplantation.

John Carethers
Mandana Khalili
Brian J. McMahon
Mary E Rinella

Review a condensed summary of the clinical research highlights from The Liver Meeting.

Michael R. Charlton

Digest a debrief of the newest data on the treatment of viral hepatitis presented at The Liver Meeting.

Marc G. Ghany

Review key highlights from all the exciting clinical research presented at The Liver Meeting® 2019.

Kathleen E. Corey

The microbiome is recognized as an important player in liver disease pathogenesis. The liver’s close proximity to the gut makes it particularly susceptible to changes in the intestinal microbiome. This workshop uses the microbiome as an example to facilitate appreciation of the tools available to perform clinical research, as well as specific research tactics for microbiome-related study.

Mamatha Bhat
Anna Mae Diehl
Herbert Tilg